Nomura Asset Management CO LTD Alnylam Pharmaceuticals, Inc. Transaction History

Nomura Asset Management CO LTD

  • $32.3 Billion
  • Q4 2024

A detailed history of Nomura Asset Management CO LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 82,785 shares of ALNY stock, worth $21.2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
82,785
Previous 85,445 3.11%
Holding current value
$21.2 Million
Previous $23.5 Million 17.12%
% of portfolio
0.06%
Previous 0.07%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$232.27 - $300.43 $617,838 - $799,143
-2,660 Reduced 3.11%
82,785 $19.5 Million
Q3 2024

Nov 15, 2024
BUY
$233.81 - $287.01 $1.44 Million - $1.76 Million
6,148 Added 7.75%
85,445 $23.5 Million
Q2 2024

Aug 14, 2024
SELL
$143.31 - $247.0 $63,916 - $110,162
-446 Reduced 0.56%
79,297 $19.3 Million
Q1 2024

May 13, 2024
BUY
$146.51 - $198.2 $1.57 Million - $2.13 Million
10,732 Added 15.55%
79,743 $11.9 Million
Q4 2023

Feb 09, 2024
BUY
$151.41 - $196.57 $150,501 - $195,390
994 Added 1.46%
69,011 $13.2 Million
Q3 2023

Nov 03, 2023
BUY
$170.77 - $211.65 $308,069 - $381,816
1,804 Added 2.72%
68,017 $12 Million
Q2 2023

Aug 14, 2023
SELL
$185.01 - $212.05 $200,735 - $230,074
-1,085 Reduced 1.61%
66,213 $12.6 Million
Q1 2023

Jan 10, 2025
BUY
$182.66 - $235.53 $1.79 Million - $2.31 Million
9,798 Added 17.04%
67,298 $13.5 Million
Q1 2023

May 11, 2023
BUY
$182.66 - $235.53 $1.79 Million - $2.31 Million
9,798 Added 17.04%
67,298 $13.5 Million
Q4 2022

Jan 10, 2025
SELL
$185.53 - $241.31 $242,673 - $315,633
-1,308 Reduced 2.22%
57,500 $13.7 Million
Q4 2022

Feb 14, 2023
SELL
$185.53 - $241.31 $242,673 - $315,633
-1,308 Reduced 2.22%
57,500 $13.7 Million
Q3 2022

Jan 10, 2025
SELL
$138.54 - $232.0 $301,463 - $504,832
-2,176 Reduced 3.57%
58,808 $11.8 Million
Q3 2022

Nov 10, 2022
SELL
$138.54 - $232.0 $301,463 - $504,832
-2,176 Reduced 3.57%
58,808 $11.8 Million
Q2 2022

Jan 10, 2025
SELL
$120.42 - $169.29 $231,928 - $326,052
-1,926 Reduced 3.06%
60,984 $8.89 Million
Q2 2022

Aug 12, 2022
SELL
$120.42 - $169.29 $231,928 - $326,052
-1,926 Reduced 3.06%
60,984 $8.89 Million
Q1 2022

Jan 10, 2025
SELL
$127.18 - $173.91 $2.87 Million - $3.92 Million
-22,535 Reduced 26.37%
62,910 $10.3 Million
Q1 2022

May 13, 2022
SELL
$127.18 - $173.91 $78,470 - $107,302
-617 Reduced 0.97%
62,910 $10.3 Million
Q4 2021

Jan 10, 2025
BUY
$159.56 - $209.29 $3.3 Million - $4.33 Million
20,703 Added 48.34%
63,527 $10.8 Million
Q4 2021

Feb 01, 2022
BUY
$159.56 - $209.29 $3.3 Million - $4.33 Million
20,703 Added 48.34%
63,527 $10.8 Million
Q3 2021

Jan 10, 2025
BUY
$169.75 - $207.73 $172,296 - $210,845
1,015 Added 2.43%
42,824 $8.09 Million
Q3 2021

Nov 12, 2021
BUY
$169.75 - $207.73 $172,296 - $210,845
1,015 Added 2.43%
42,824 $8.09 Million
Q2 2021

Jan 10, 2025
BUY
$128.63 - $176.89 $153,712 - $211,383
1,195 Added 2.94%
41,809 $7.09 Million
Q2 2021

Aug 06, 2021
BUY
$128.63 - $176.89 $153,712 - $211,383
1,195 Added 2.94%
41,809 $7.09 Million
Q1 2021

Jan 10, 2025
SELL
$126.83 - $175.69 $5.69 Million - $7.88 Million
-44,831 Reduced 52.47%
40,614 $5.73 Million
Q1 2021

May 14, 2021
BUY
$126.83 - $175.69 $2.55 Million - $3.53 Million
20,099 Added 97.97%
40,614 $5.73 Million
Q4 2020

Jan 10, 2025
SELL
$122.97 - $147.0 $7.98 Million - $9.54 Million
-64,930 Reduced 75.99%
20,515 $2.67 Million
Q4 2020

Feb 12, 2021
BUY
$122.97 - $147.0 $174,617 - $208,740
1,420 Added 7.44%
20,515 $2.67 Million
Q2 2020

Aug 13, 2020
BUY
$104.21 - $156.44 $52,626 - $79,002
505 Added 2.72%
19,095 $2.83 Million
Q1 2020

May 14, 2020
BUY
$93.12 - $133.99 $93,120 - $133,990
1,000 Added 5.69%
18,590 $2.02 Million
Q4 2019

Feb 13, 2020
SELL
$74.51 - $124.23 $38,000 - $63,357
-510 Reduced 2.82%
17,590 $2.03 Million
Q3 2019

Nov 13, 2019
BUY
$70.9 - $87.82 $323,304 - $400,459
4,560 Added 33.68%
18,100 $1.46 Million
Q4 2018

Feb 12, 2019
BUY
$62.67 - $88.33 $100,272 - $141,328
1,600 Added 13.4%
13,540 $987,000
Q2 2018

Aug 03, 2018
BUY
$88.31 - $107.8 $105,972 - $129,360
1,200 Added 11.17%
11,940 $1.18 Million
Q4 2017

Feb 14, 2018
BUY
$114.49 - $139.98 $1.23 Million - $1.5 Million
10,740 New
10,740 $1.37 Million
Q3 2017

Nov 13, 2017
BUY
$72.53 - $118.27 $0 - $0
0
0 $0

Others Institutions Holding ALNY

# of Institutions
673
Shares Held
112M
Call Options Held
943K
Put Options Held
922K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.6B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email